Suppr超能文献

呼吸道合胞病毒感染儿童复发性喘息的早期风险识别

Early risk identification for recurrent wheezing in children with respiratory syncytial virus infections.

作者信息

Wang Ying, Shi Yalin, Wang Lijuan

机构信息

Department of Pediatric Cardiovascular and Respiratory Medicine, Xianyang Rainbow Hospital Xianyang 712000, Shaanxi, China.

Department of Pediatric Respiratory Medicine, Xianyang Rainbow Hospital Xianyang 712000, Shaanxi, China.

出版信息

Am J Transl Res. 2025 Jul 15;17(7):5411-5422. doi: 10.62347/FBSN3075. eCollection 2025.

Abstract

OBJECTIVE

To evaluate the predictive value of peripheral blood eosinophil (EOS) count and nasopharyngeal microbiota for recurrent wheezing in children following respiratory syncytial virus (RSV) lower respiratory tract infections.

METHODS

This retrospective study included 614 children with RSV infection and an external validation cohort of 164 children. Clinical data, hematological parameters, and nasopharyngeal microbiota profiles were collected. Logistic regression was used to identify independent predictors of recurrent wheezing. A predictive model was developed and validated using receiver operating characteristic (ROC) and calibration curves.

RESULTS

Peripheral blood EOS count, serum 25(OH)D and IgM levels, and nasopharyngeal bacterial colonization (notably and ) were significantly associated with recurrent wheezing. The predictive model showed moderate-to-good diagnostic performance (AUC = 0.747) and consistent accuracy in the external validation cohort (AUC = 0.741).

CONCLUSION

Peripheral blood EOS count and nasopharyngeal microbiota composition are critical predictors of recurrent wheezing following RSV infection. The predictive model may aid in early risk stratification and personalized intervention to prevent recurrent wheezing in pediatric patients.

摘要

目的

评估外周血嗜酸性粒细胞(EOS)计数和鼻咽部微生物群对呼吸道合胞病毒(RSV)下呼吸道感染后儿童反复喘息的预测价值。

方法

这项回顾性研究纳入了614例RSV感染儿童和一个由164例儿童组成的外部验证队列。收集了临床数据、血液学参数和鼻咽部微生物群谱。采用逻辑回归分析确定反复喘息的独立预测因素。利用受试者工作特征(ROC)曲线和校准曲线建立并验证了预测模型。

结果

外周血EOS计数、血清25(OH)D和IgM水平以及鼻咽部细菌定植(尤其是 和 )与反复喘息显著相关。该预测模型显示出中度至良好的诊断性能(AUC = 0.747),且在外部验证队列中具有一致的准确性(AUC = 0.741)。

结论

外周血EOS计数和鼻咽部微生物群组成是RSV感染后反复喘息的关键预测因素。该预测模型可能有助于早期风险分层和个性化干预,以预防儿科患者反复喘息。

相似文献

1
Early risk identification for recurrent wheezing in children with respiratory syncytial virus infections.
Am J Transl Res. 2025 Jul 15;17(7):5411-5422. doi: 10.62347/FBSN3075. eCollection 2025.
2
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.
Cochrane Database Syst Rev. 2025 Jul 23;7(7):CD013757. doi: 10.1002/14651858.CD013757.pub3.
5
Lower respiratory tract co-infection of and respiratory syncytial virus shapes microbial landscape and clinical outcomes in children.
Front Cell Infect Microbiol. 2025 Jun 9;15:1593053. doi: 10.3389/fcimb.2025.1593053. eCollection 2025.
6
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013757. doi: 10.1002/14651858.CD013757.pub2.
7
[Clinical characteristics of severe human metapneumovirus infection in children and analysis of risk factors for critical illness].
Zhonghua Er Ke Za Zhi. 2025 Aug 2;63(8):864-869. doi: 10.3760/cma.j.cn112140-20250228-00160.
8
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.

本文引用的文献

1
Antibody Response to Respiratory Syncytial Virus Vaccination in Immunocompromised Persons.
JAMA. 2025 Feb 4;333(5):429-432. doi: 10.1001/jama.2024.25395.
2
[Expert consensus on the passive immunization prevention of infant respiratory syncytial virus infection in China].
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Dec 6;58(12):1853-1865. doi: 10.3760/cma.j.cn112150-20240826-00684.
3
Respiratory Syncytial Virus Prevalence and Risk Factors among Healthy Term Infants, United States.
Emerg Infect Dis. 2024 Oct;30(10):2199-2202. doi: 10.3201/eid3010.240609.
4
Early-life respiratory syncytial virus disease and long-term respiratory health.
Lancet Respir Med. 2024 Oct;12(10):810-821. doi: 10.1016/S2213-2600(24)00246-7. Epub 2024 Sep 9.
5
Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children.
Lancet. 2024 Sep 21;404(10458):1157-1170. doi: 10.1016/S0140-6736(24)01699-4. Epub 2024 Sep 9.
6
Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies.
Lancet. 2024 Sep 21;404(10458):1143-1156. doi: 10.1016/S0140-6736(24)01716-1. Epub 2024 Sep 9.
9
Discovery and Validation of a Volatile Signature of Eosinophilic Airway Inflammation in Asthma.
Am J Respir Crit Care Med. 2024 Nov 1;210(9):1101-1112. doi: 10.1164/rccm.202310-1759OC.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验